Satu Mustjoki Selected Research

Satu Mustjoki Research Topics

Disease

50	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 04/2024 - 08/2010
44	Neoplasms (Cancer) 04/2024 - 08/2008
17	Leukemia 11/2023 - 08/2008
11	Large Granular Lymphocytic Leukemia 01/2023 - 04/2011
7	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 04/2024 - 10/2009
7	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 01/2023 - 07/2014
6	Melanoma (Melanoma, Malignant) 01/2023 - 01/2017
5	Philadelphia Chromosome 03/2022 - 08/2008
4	Renal Cell Carcinoma (Grawitz Tumor) 01/2023 - 05/2015
4	Rheumatoid Arthritis 01/2021 - 01/2018
3	Pleural Effusion (Pleural Effusions) 01/2022 - 04/2011
3	T-Cell Prolymphocytic Leukemia (Leukemia, T Cell, Chronic) 01/2021 - 01/2018
3	Disease Progression 01/2019 - 01/2011
3	Blast Crisis (Blast Phase) 04/2017 - 05/2016
2	Breast Neoplasms (Breast Cancer) 04/2024 - 01/2017
2	Lymphoma (Lymphomas) 01/2023 - 01/2020
2	T-Cell Leukemia (Leukemia, T Cell) 01/2023 - 01/2020
2	Inflammation (Inflammations) 01/2020 - 01/2019
2	Autoimmune Diseases (Autoimmune Disease) 01/2019 - 01/2018
2	Agammaglobulinemia (Hypogammaglobulinemia) 08/2017 - 01/2014
2	Lymphocytosis 05/2016 - 08/2010
1	Precursor T-Cell Lymphoblastic Leukemia-Lymphoma (T-ALL) 04/2024
1	Arthritis (Polyarthritis) 04/2024
1	Ovarian Neoplasms (Ovarian Cancer) 02/2024
1	DNA Repair-Deficiency Disorders (Chromosome Instability Syndromes) 02/2024
1	Anaplastic Large-Cell Lymphoma (Ki 1 Lymphoma) 01/2023
1	Non-Hodgkin Lymphoma (Lymphosarcoma) 01/2023
1	Adult T-Cell Leukemia-Lymphoma (Leukemia Lymphoma, T Cell, Acute, HTLV I Associated) 01/2023
1	Aplastic Anemia (Anemia, Hypoplastic) 01/2022
1	idiopathic Aplastic anemia 12/2021
1	Bone Marrow Failure Disorders 12/2021
1	Hepatocellular Carcinoma (Hepatoma) 01/2021
1	Common Variable Immunodeficiency 12/2020

Drug/Important Bio-Agent (IBA)

32	Tyrosine Kinase InhibitorsIBA 04/2024 - 06/2009
17	Dasatinib (BMS 354825)FDA Link 02/2024 - 08/2008
10	T-Cell Antigen Receptors (T-Cell Receptor)IBA 04/2024 - 08/2010
10	Imatinib Mesylate (Gleevec)FDA Link 12/2023 - 08/2008
7	RNA (Ribonucleic Acid)IBA 04/2024 - 11/2020
7	Proteins (Proteins, Gene)FDA Link 12/2023 - 01/2011
6	Phosphotransferases (Kinase)IBA 04/2024 - 08/2008
6	CytokinesIBA 04/2024 - 01/2011
6	AntigensIBA 11/2023 - 01/2011
6	InterferonsIBA 01/2020 - 01/2011
5	venetoclaxIBA 01/2023 - 01/2019
4	AntibodiesIBA 01/2024 - 12/2016
4	nilotinib FDA Link 06/2023 - 08/2016
4	Biomarkers (Surrogate Marker)IBA 01/2022 - 01/2018
4	Peptides (Polypeptides)IBA 01/2021 - 01/2020
3	DNA (Deoxyribonucleic Acid)IBA 02/2024 - 01/2021
3	Death Domain ReceptorsIBA 12/2023 - 01/2013
3	STAT3 Transcription Factor (Signal Transducer and Activator of Transcription 3)IBA 01/2023 - 05/2012
3	navitoclaxIBA 01/2023 - 01/2019
3	EpitopesIBA 01/2021 - 01/2018
3	Immunoglobulin G (IgG)IBA 01/2021 - 01/2014
3	LigandsIBA 04/2020 - 01/2013
2	Protein-Tyrosine Kinases (Tyrosine Kinase)IBA 04/2024 - 01/2011
2	NivolumabIBA 01/2023 - 01/2021
2	GlucocorticoidsIBA 01/2021 - 01/2021
2	RG7388IBA 01/2021 - 01/2021
2	Drug CombinationsIBA 01/2021 - 01/2018
2	Immune Checkpoint InhibitorsIBA 01/2021 - 01/2021
2	Oncogene Proteins (Oncogene Protein)IBA 01/2017 - 01/2011
1	Electron Transport Complex I (NADH-CoQ Reductase)IBA 04/2024
1	olaparibIBA 02/2024
1	Carboplatin (JM8)FDA LinkGeneric 02/2024
1	Messenger RNA (mRNA)IBA 02/2024
1	Glycoproteins (Glycoprotein)IBA 12/2023
1	Interferon Type IIBA 12/2023
1	Apoptosis Regulatory ProteinsIBA 10/2023
1	snake venom protein C activatorIBA 10/2023
1	Small Cytoplasmic RNAIBA 01/2023
1	A-1331852IBA 01/2023
1	Anaplastic Lymphoma KinaseIBA 01/2023
1	IgA receptor (protein B)IBA 01/2023
1	HLA-DR Antigens (HLA-DR)IBA 01/2022
1	AutoantibodiesIBA 01/2022
1	Interleukin-8 (Interleukin 8)IBA 01/2022
1	ChemokinesIBA 01/2022
1	HLA Antigens (Human Leukocyte Antigens)IBA 12/2021
1	Granzymes (Granzyme)IBA 01/2021
1	ruxolitinibIBA 01/2021
1	Dexamethasone (Maxidex)FDA LinkGeneric 01/2021
1	Hepatitis B e AntigensIBA 01/2021
1	Histone Deacetylase InhibitorsIBA 01/2021
1	Antiviral Agents (Antivirals)IBA 01/2021
1	S63845IBA 01/2021
1	tipifarnib (R115777)IBA 01/2021
1	Farnesyltranstransferase (Farnesyltransferase)IBA 01/2021
1	atezolizumabIBA 01/2021
1	Janus Kinase InhibitorsIBA 01/2021
1	Bendamustine Hydrochloride FDA Link 01/2021
1	Immunoglobulin A (IgA)IBA 01/2021
1	Complementarity Determining Regions (Complementarity Determining Region)IBA 12/2020
1	Indoleamine-Pyrrole 2,3,-Dioxygenase (Indoleamine 2,3 Dioxygenase)IBA 04/2020

Therapy/Procedure

45	Therapeutics 12/2023 - 08/2008
12	Immunotherapy 01/2023 - 01/2013
6	Drug Therapy (Chemotherapy) 04/2024 - 10/2009
2	Aftercare (After-Treatment) 01/2020 - 05/2016
1	Precision Medicine 01/2022
1	Nephrectomy 01/2022